ALLIANCEBERNSTEIN L.P. - ANAPTYSBIO INC ownership

ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 133 filers reported holding ANAPTYSBIO INC in Q3 2020. The put-call ratio across all filers is 62.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of ANAPTYSBIO INC
ValueSharesWeighting
Q3 2023$549,396
-16.9%
30,590
-5.9%
0.00%
Q2 2023$661,457
+6.3%
32,520
+13.7%
0.00%
Q1 2023$622,336
-38.4%
28,600
-12.3%
0.00%
Q4 2022$1,010,274
+21.4%
32,6000.0%0.00%
Q3 2022$832,000
+25.7%
32,6000.0%0.00%
Q2 2022$662,000
-6.1%
32,600
+14.4%
0.00%
Q1 2022$705,000
-28.6%
28,500
+0.4%
0.00%
Q4 2021$987,000
+19.8%
28,400
-6.6%
0.00%
Q3 2021$824,000
+4.6%
30,4000.0%0.00%
Q2 2021$788,000
+32.9%
30,400
+10.5%
0.00%
Q1 2021$593,000
-11.4%
27,500
-11.6%
0.00%
Q4 2020$669,000
+40.8%
31,100
-3.4%
0.00%
Q3 2020$475,000
-33.9%
32,2000.0%0.00%
Q2 2020$719,000
+39.3%
32,200
-11.7%
0.00%
Q1 2020$516,000
-71.2%
36,486
-66.9%
0.00%
-100.0%
Q4 2019$1,790,000
+40.2%
110,130
+201.8%
0.00%0.0%
Q3 2019$1,277,000
-36.6%
36,486
+2.2%
0.00%0.0%
Q2 2019$2,013,000
-4.0%
35,686
+24.4%
0.00%0.0%
Q1 2019$2,096,000
-51.7%
28,686
-57.9%
0.00%
-66.7%
Q4 2018$4,343,000
+54.4%
68,086
+141.6%
0.00%
+50.0%
Q3 2018$2,812,000
+40.5%
28,1860.0%0.00%
+100.0%
Q2 2018$2,002,000
-20.5%
28,186
+16.5%
0.00%
-50.0%
Q1 2018$2,517,000
+19.1%
24,186
+15.2%
0.00%0.0%
Q4 2017$2,114,00020,9860.00%
Other shareholders
ANAPTYSBIO INC shareholders Q3 2020
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 1,950,609$35,032,9384.94%
EcoR1 Capital, LLC 7,521,024$135,077,5914.56%
Saturn V Capital Management LP 577,101$10,364,7344.34%
GREAT POINT PARTNERS LLC 894,333$16,062,2212.93%
5AM Venture Management, LLC 357,733$6,424,8851.85%
First Light Asset Management, LLC 790,806$14,202,8761.35%
Boxer Capital, LLC 1,300,000$23,348,0001.24%
Frazier Life Sciences Management, L.P. 899,700$16,158,6121.07%
Deep Track Capital, LP 1,345,813$24,170,8010.93%
Palo Alto Investors LP 431,224$7,744,7830.73%
View complete list of ANAPTYSBIO INC shareholders